The probability that screening mammography saved a womans life is less than 25 percent, according to an article published Oct. 24 in the Archives of Internal Medicine. The accompanying commentary advocated for clinicians to share a simple scientific message that does not inflate the survival benefit of screening mammography.

Under the Centers for Medicare & Medicaid Services' (CMS) final e-prescribing rule the deadline to apply for additional hardship exemptions and avoid the 2012 e-prescribing penalty is Nov. 1. The American College of Cardiology (ACC) is encouraging eligible professionals to apply for exemptions via the CMS web-based portal.

To help put the kibosh on a possible link between angiotensin II receptor antagonists (ARBs) and new cancers, the European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) has concluded that previous evidence does not support any increased risk of cancer in patients administered ARBs.

Thomas Jefferson University (TJU) Hospital in Philadelphia is the latest in a small number of medical centers nationwide to begin offering Cysview, a recently approved optical imaging agent, for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer.

Agilent Technologies and the University of Technology, Sydney in Australia have established a joint nuclear MR research facility.

Treating ischemic stroke patients with statins at the beginning of hospitalization and avoiding interruptions in statin use for stroke patients who already were taking statins may be a prudent course of care, based on results of a study published online Oct. 20 in Stroke. 

Total nuclear medicine procedures have been relatively flat, and trending slightly downward, from 2007 to 2010, according to a report from IMV Medical Information Division.

Bracco Diagnostics has sent its customers an update regarding its voluntary recall of the CardioGen-82 rubidium generator. The company indicated that user error, a higher than expected strontium breakthrough, or a combination of both factors likely accounted for the triggering of gamma ray emission sensors by two patients crossing the U.S. border in July.